Market Expertise
Niche market understanding means that we develop ontologies and analytical tools tailored to the needs of fast-moving, emerging therapeutic modalities.
Unmatched Data Quality
Timely, accurate, comprehensive data with a zero-tolerance approach to errors and inaccuracies – ensuring you have confidence in your research.
Customer Centric
Close client relationships enable continued agile product development and evolution to meet your emerging needs.
Our Dataset Solutions
Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more
Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more
Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.
Beacon Cell Therapy covers genetically and non-genetically engineered allogeneic and autologous cell-based therapies across all disease indications.
Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets
Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.
Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.
From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.
Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.
Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.
From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.
Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.
Beacon TPD provides the solution you need to master the targeted protein degradation field.
What our customers say
“Beacon is helpful when I need data on the fly. I find it valuable to be able to go through the platform quickly and see the up to date status of ADCs and targets”
Chief Development Officer
BioPharma Consulting
"Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything."
Director
Small Biotech
Download our Brochure
Discover how Beacon can improve your capabilities in developing complex therapeutics by downloading our brochure and exploring the Drugs & Trials database solutions.
Book a Demonstration
Ready to unlock the full potential of Beacon? Schedule a personalized demo now and discover how our innovative solution can transform your approach to therapeutic development.
Our Latest Content
In Vivo CAR Therapies – Cell Therapy Digest
Navigating the Complex Landscape of SKYSONA and Hematologic Cancer Report 2024
Strategic Insights for Biopharma Innovation Report
H1 2024 Oncolytic Viruses Landscape Review
H1 2024 Cytokine Landscape Review
H1 2024 Cancer Vaccine Landscape Review
H1 2024 Microbiome Landscape Review
The 2024 H1 TPD Landscape Review
